[ad_1]
The director general of the Butantan Institute, Dimas Covas, said that the National Sanitary Surveillance Agency (Anvisa) is hindering the production of the CoronaVac vaccine by delaying the authorization to import raw materials from China. The information is from the columnist Mônica Bergamo, from Folha de S. Paulo.
+ Anvisa says that order to import supplies to Coronavac is being analyzed
According to Dimas, there was a request for the product launch on September 23 to manufacture 40 million doses. However, on Thursday (22), the president of Butantan said that the matter will be discussed in a meeting on November 11.
Dimas said that if the launch occurs in November, the production of the first doses of the vaccine will only be ready in January, delaying a large-scale immunization of the Brazilian population.
see also
+ The incredible story of the Jew who worked for the Nazis in Greece
+ Was emergency assistance denied? Follow 3 steps to compete in Dataprev
+ Caixa replaces the pause in real estate financing discounting up to 50% of the fee
+ Santo Stefano: This Italian town pays you R $ 52,000 to move
+ A 6,500-year-old copper workshop discovered in the desert of Israel
+ Video shows cougar chasing a trail runner in the US
+ Shark is captured in MA with remains of missing youths in stomach
+ 12 reasons that can make you menstruate twice a month
+ Can burping a lot be a health problem?
+ Educating is more important than collecting
[ad_2]
